⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5084465 | 0.84 | — | — | |
| SCHEMBL13693405 | 0.70 | — | — | |
| SCHEMBL12390040 | 0.65 | — | — | |
| SCHEMBL2594264 | 0.63 | — | — | |
| SCHEMBL12390048 | 0.62 | — | — | |
| SCHEMBL27915065 | 0.61 | — | — | |
| SCHEMBL16375058 | 0.61 | — | — | |
| SCHEMBL183631 | 0.61 | — | — | |
| SCHEMBL3006936 | 0.59 | — | — | |
| SCHEMBL27537589 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121377973-A | Preparation method of 2-cyclopentenone | 南通华祥医药科技有限公司 | 2026-01-23 | — | — | CN | disclosed |
| CN-111183136-B | Amber odorant | 弗门尼舍有限公司 | 2024-05-28 | — | — | CN | disclosed |
| EP-3668850-B1 | AMBER ODORANT | FIRMENICH & CIE (CH) | 2021-07-14 | — | — | EP | disclosed |
| US-10889558-B2 | Amber odorant | FIRMENICH SA (CH) | 2021-01-12 | — | — | US | disclosed |
| US-20200299254-A1 | AMBER ODORANT | FIRMENICH SA (CH) | 2020-09-24 | — | — | US | disclosed |
| EP-3668850-A1 | AMBER ODORANT | Firmenich SA (CH) | 2020-06-24 | — | — | EP | disclosed |
| CN-111183136-A | Amber odorant | 弗门尼舍有限公司 | 2020-05-19 | — | — | CN | disclosed |
| US-20080003288-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2008-01-03 | — | — | US | disclosed |
| US-7204997-B2 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2007-04-17 | — | — | US | disclosed |
| EP-1478403-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA, INC. (CA) | 2004-11-24 | — | — | EP | disclosed |
| US-20030152623-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2003-08-14 | — | — | US | disclosed |
| WO-2003063909-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| EP-0910351-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-28 | — | — | EP | disclosed |
| EP-0907666-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997049736-A2 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
| WO-1997049387-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |